GlassScriptPhysician profile
Gino Chiappetta
NPI 1124141858
$162,458.10
in general payments reported to CMS, 2019-2025
28 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,274 · 2020: $38K · 2021: $25K · 2022: $29K · 2023: $29K · 2024: $20K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $60K · Food and Beverage: $4,199 · Consulting Fee: $1,750 · Travel and Lodging: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $60,195.19 |
| Food and Beverage | $4,199.47 |
| Consulting Fee | $1,750.00 |
| Travel and Lodging | $907.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $117,397.56 | 2019-2023 | Modulus, Tlif, Acp |
| Globus Medical, INC. | $35,822.39 | 2024-2025 | Modulus, Modulus, Creo S2ai |
| 4web, INC. | $2,441.62 | 2023-2024 | Spine Truss System |
| Mirus, LLC | $1,073.51 | 2023 | Cygnus Anterior Cervical Plate, 3dr Lumbar Interbody, Europa Pedicle Screw System |
| Stryker Corporation | $997.26 | 2019-2024 | Gamma |
| Alphatec Spine, INC | $927.81 | 2021-2025 | Other - Miscellaneous, Safeop, Battalion Tlif - PC |
| Nevro Corp. | $912.13 | 2019-2023 | Senza |
| Intrinsic Therapeutics | $370.84 | 2020-2025 | Barricaid Acd (Annular Closure Device) |
| Baxter Healthcare | $357.05 | 2019-2025 | Floseal |
| Boston Scientific Corporation | $342.18 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $339.27 | 2020-2024 | Symphony |
| Abbott Laboratories | $260.10 | 2021-2023 | Proclaim |
| Biocomposites INC | $151.17 | 2025 | Stimulan |
| Avanos Medical | $147.72 | 2020-2023 | On-Q* Pump and Accessories |
| Mml US, INC. | $147.50 | 2023 | Reactiv8 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $125.00 | 2020 | |
| Medtronic USA, INC. | $117.23 | 2019 | |
| Si-Bone, INC. | $107.59 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $100.97 | 2019 | |
| Providence Medical Technology, INC. | $54.21 | 2025 | |
| Spinal Elements, INC. | $48.90 | 2024 | |
| Medtronic, INC. | $47.99 | 2023-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Cerapedics INC. | $44.49 | 2019 | |
| Ossdsign USA Incorporated | $41.74 | 2023 | |
| Baudax Bio INC. | $35.12 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $31.74 | 2025 | |
| Acera Surgical, INC. | $15.01 | 2025 | Restrata Wound Matrix |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,000,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gino Chiappetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.